Tilray, Inc. Reports 2020 Second Quarter Results Revenue Increased 10% to $50.4 Million (C$69.4 Million) versus Q2 2019 Cost Savings of $13.0 Million Realized in Q2 2020 – on Pace for Total Annualized Savings of Approximately $55 Million Net Loss of ($81.7) Million increased $45.4 Million versus Q2 2019... Read more
Columbia Care Reports Record Second Quarter 2020 Financial Results Driven by Organic Revenue Growth and Margin Improvements 2Q Combined Revenue Record of $33.0 Million, an Increase of 71% YoY, up 14% Sequentially Combined Gross Margin of 36.1%, Reflecting Increase of 800 Basis Points (“BP”) YoY, up 480 BP Sequentially... Read more
A new documentary slated for release later this month takes an in-depth look at the science behind cannabis as medicine, from the groundbreaking researchers who first discovered the curative power of cannabinoids to the pioneering patients whose lives have been transformed by the plant. The documentary from Mad Machine... Read more
Canada just announced that four patients who have been diagnosed with terminal cancer will receive therapy from psilocybin, the psychoactive component in mushrooms. The idea is for the patients to come to terms with their lives ending through the use of psilocybin. This comes over 100 days after a... Read more
An Arizona voter initiative that would legalize the recreational use of cannabis by adults has survived a legal challenge by opponents, who argued that the ballot summary for the measure failed to properly inform voters. In a ruling released on Friday, Judge James Smith rejected all arguments of attorneys... Read more
Oregon officials finalized a series of analyses this week on separate ballot measures to legalize psilocybin mushrooms for therapeutic use and decriminalize drugs while investing in substance misuse treatment. The Oregon Criminal Justice Commission determined that the decriminalization initiative would reduce felony and misdemeanor convictions for drug possession by... Read more
Oregon officials finalized a series of analyses this week on separate ballot measures to legalize psilocybin mushrooms for therapeutic use and decriminalize drugs while investing in substance misuse treatment. The Oregon Criminal Justice Commission determined that the decriminalization initiative would reduce felony and misdemeanor convictions for drug possession by... Read more
Hemp and CBD leaders told Hemp Industry Daily what they hope to see in the FDA’s Enforcement Policy draft guidance, when the industry will likely get to see that document and what will happen to the industry if FDA regulatory guidance on CBD doesn’t come soon. (Click on the... Read more
Canopy Growth Reports First Quarter Fiscal 2021 Financial Results Transformation strategy gains traction Net Revenue of $110 million increases 22% over Q1 FY20 Net Loss of $128 million; Adjusted EBITDA loss of $92 million narrows versus Q1 FY20 Established leadership position in growing cannabis-infused beverage segment; shipping +1.2mm cans... Read more
